Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human SCARB2/CD36L2 Antibody (SAA0777)

Catalog #:   FHG70410 Specific References (49) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: Blocking, ELISA, FCM, WB
Accession: Q14108
Overview

Catalog No.

FHG70410

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Conjugation

Unconjugated

Target

CD36, 85 kDa lysosomal membrane sialoglycoprotein, CD36 antigen-like 2, CD36L2, SCARB2, Lysosome membrane protein 2, LIMP II, Scavenger receptor class B member 2, Lysosome membrane protein II, LIMPII, LIMP2, LGP85

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q14108

Applications

Blocking, ELISA, FCM, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.09% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0777

Data Image
References

Plasminogen deficiency reduces disease severity and immune responses in enterovirus A71-infected mice., PMID:40377310

Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2., PMID:39424982

Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection., PMID:37262073

Dual blockages of a broad and potent neutralizing IgM antibody targeting GH loop of EV-As., PMID:36726218

Molecular mechanism of antibody neutralization of coxsackievirus A16., PMID:36543790

Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage., PMID:35579435

TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice., PMID:35501179

Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71)., PMID:34770987

Engineering a novel IgG-like bispecific antibody against enterovirus A71., PMID:34095549

A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model., PMID:34044752

Dominant atopy risk mutations identified by mouse forward genetic analysis., PMID:32810290

Development of an Enterovirus 71 Vaccine Efficacy Test Using Human Scavenger Receptor B2 Transgenic Mice., PMID:31896594

A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge., PMID:30013088

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71., PMID:29970466

Visualization and Measurement of Multiple Components of the Autophagy Flux., PMID:29936691

VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection., PMID:29848582

Prokaryotic expression and identification of scavenger receptor B2., PMID:29521103

The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection., PMID:28447294

Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity., PMID:28422137

Update on systemic vasculitides., PMID:28377447

Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology., PMID:27387826

A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice., PMID:27102822

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody., PMID:26938634

The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate., PMID:26430888

Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry., PMID:26401034

Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy., PMID:26304790

Mannose 6-phosphate-independent Lysosomal Sorting of LIMP-2., PMID:26219725

SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7., PMID:25862818

Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis., PMID:24212238

Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy., PMID:24098578

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice., PMID:23936115

Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novel SCARB2 mutations., PMID:23659519

Abnormal Processing of Autophagosomes in Transformed B Lymphocytes from SCARB2-Deficient Subjects., PMID:23515316

Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport., PMID:21454587

Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2., PMID:21429972

Distribution of smooth muscle cells and macrophages expressing scavenger receptor BI/II in atherosclerosis., PMID:20032583

Scavenger receptor B2 is a cellular receptor for enterovirus 71., PMID:19543282

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity., PMID:17215280

DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge., PMID:17005675

DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses., PMID:16563575

Molecular characterization of rabbit scavenger receptor class B types I and II: portal to central vein gradient of expression in the liver., PMID:14595001

A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology., PMID:12356916

Human retinal pigment epithelial cells express scavenger receptors BI and BII., PMID:11944916

CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting., PMID:11581410

Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine., PMID:11369797

Limited and selective localization of the lysosomal membrane glycoproteins LGP85 and LGP96 in rat osteoclasts., PMID:10219623

Microtubule reorganization and lysosome redistribution by a viral v-src oncogene, in mouse Balb/3T3 cells expressing human EGF receptor., PMID:7720100

Cycling of an 85-kDa lysosomal membrane glycoprotein between the cell surface and lysosomes in cultured rat hepatocytes., PMID:7852289

Lysosomal targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a particular position in its cytoplasmic tail., PMID:8106503

Datasheet
$ 225
Product specifications
50 μg 225 100 μg 372

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human SCARB2/CD36L2 Antibody (SAA0777) [FHG70410]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only